Home Journals Articles Updates About
CN
image
收藏切换
Global approved new drugs in 2020: retrospect and prospect
收藏切换
Meng WU1, You-song SUN2, Qian CHEN2, Zhen-zheng YANG3, Xiao-nan ZHENG1, 3
Chinese Journal of New Drugs | 2021, 30(10) : 905 - 914
Less
收藏切换
Chinese Journal of New Drugs | 2021, 30(10): 905-914
Global approved new drugs in 2020: retrospect and prospect
Full
Meng WU1, You-song SUN2, Qian CHEN2, Zhen-zheng YANG3, Xiao-nan ZHENG1, 3
Affiliations
  • 1School of Science, China Pharmaceutical University, Nanjing 210009, China
  • 2Shanghai Pharma Digger Technology Co., Ltd., Shanghai 201210, China
  • 3Editorial Office of Progress in Pharmaceutical Sciences, China Pharmaceutical University, Nanjing 210009, China
Published: 2021-05-30
Outline
收藏切换

The COVID-19 epidemic has swept the world in 2020, posing a major threat to human life and health. The global biopharmaceutical landscape will also change. The Center for Drug Evaluation and Research (CDER) of the US FDA approved 53 innovative drugs in 2020, 40 of which were first approved worldwide. The European EMA approved 34 innovative medicines throughout the year, including 6 for the first approval in the world. Japan's Medical Products and Medical Devices Agency (PMDA) approved 38 innovative drugs throughout the year, including 13 for the first approval in the world. National Medical Products Administration (NMPA) approved 48 innovative drugs throughout the year, 9 of which were developed by local companies and approved for the first time in the world. The launch of these new drugs will provide brand new therapies or more treatment options for a variety of diseases. This paper reviewed the new drugs approved for the market in the US, EU, Japan and China in 2020, and gave a brief outlook on the new drug development in 2021, aiming to provide reference for people engaged in new drug research and development.

original new drug  /  first approval  /  antitumor drug  /  orphan drug  /  antibody drug
吴孟, 孙友松, 陈倩, 杨臻峥, 郑晓南. 2020年全球获批上市的原创新药：回顾与展望. 中国新药杂志, 2021 , 30 (10) : 905 -914 .
Meng WU, You-song SUN, Qian CHEN, Zhen-zheng YANG, Xiao-nan ZHENG. Global approved new drugs in 2020: retrospect and prospect[J]. Chinese Journal of New Drugs, 2021 , 30 (10) : 905 -914 .
Appendix
Less
Year 2021 volume 30 Issue 10
45
7
Cite this Article
BibTeX
Article Info
  • Online Date：2026-10-28
  • Published：2021-05-30
Article Data
Affiliations
History
  • Accepted：2021-04-08
Affiliations
    1School of Science, China Pharmaceutical University, Nanjing 210009, China
    2Shanghai Pharma Digger Technology Co., Ltd., Shanghai 201210, China
    3Editorial Office of Progress in Pharmaceutical Sciences, China Pharmaceutical University, Nanjing 210009, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family		 属数
Number of
genus		 种数
Number of
species		 占总种数比例
Percentage of
total species (%)		 属
Genus		 种数
Number of
species		 占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT
Links
Articles
Latest Articles
Most Read
Collections
Updates
Events
News
Multimedia
About
About Us
Contact
No. 86 Xueyuan South Road, Haidian District, Beijing
100081
010-62662699(Operation and Technical Support)
qkjq@cast.org.cn

Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House